Global Health Ltd. (MEDANTA)
NSE
1,260.60
+48.60 (+4.01%)
Closed
Oct 27, 2026
Day's Range
1,205.101,272.90
52 wk Range
956.001,544.00
Financial Statements - MEDANTA - Global Health Ltd.
Revenue
43.18B▲ 18.7%
Net Income
5.54B▲ 15.1%Net Margin 12.8%
EBITDA
10.33B▲ 3.4%
Free Cash Flow
-2.64B▼ 993.7%
Income Statement
| Period Ending | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|---|
| Sales | 43.18B | 36.36B | 32.40B | 26.82B | 21.67B | 14.29B |
| Cost of Goods | 9.96B | 8.79B | 7.59B | 6.25B | 5.42B | 3.48B |
| Gross Profit | 33.21B | 27.57B | 24.81B | 20.57B | 16.24B | 10.80B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 7.26B | 7.36B | 6.67B | 4.99B | 3.24B | 926.97M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 7.15B | 6.47B | 6.27B | 4.49B | 2.80B | 324.64M |
| Income Tax | 1.60B | 1.65B | 1.49B | 1.23B | 843.59M | 36.59M |
| Net Income | 5.54B | 4.81B | 4.78B | 3.26B | 1.96B | 288.05M |
| EPS Basic | 20.71 | 17.92 | 17.8 | 12.58 | 7.747618 | 1.15 |
| EPS Diluted | 20.66 | 17.92 | 17.8 | 12.57 | 7.73497 | 1.14 |
| Basic Shares Outstanding | 268.75M | 268.60M | 268.60M | 259.20M | 253.23M | 251.40M |
| Diluted Shares Outstanding | 268.75M | 268.60M | 268.60M | 259.20M | 253.23M | 251.40M |
| Ebit | 7.93B | 7.11B | 6.99B | 5.26B | 3.60B | 995.65M |
| Ebitda | 10.33B | 9.99B | 9B | 6.84B | 4.93B | 2.34B |
| Net Income Continuous Operations | 7.15B | 6.47B | 6.27B | 4.49B | 2.80B | 324.64M |
| Minority Interests | 23.92M | 1.19M | 1.34M | 0 | 0 | 0 |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
